Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-09-30

Clinical Trial Update: MultiPoint Pacing IDE Study [Phase 3]

View source ↗

Summary

Abbott completed a Phase 3 IDE study evaluating MultiPoint Pacing for heart failure; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MultiPoint Pacing IDE

Snippet

Sponsor: Abbott Medical Devices | Conditions: Heart Failure | Phase 3 | Status: COMPLETED | Results posted: 2016-09-30